Health & Medicine
-
Toe Hair Presence or Absence May Reveal Health Issues
BOSTON, June 18 — As warm weather returns, people are paying attention to the aesthetics of their feet, including their toe hair.…
-
Family doctors key for new immigrants in Israel’s healthcare
Jerusalem, June 18 — For new immigrants in Israel, understanding the healthcare system can be overwhelming, but physicians from Clalit, the country’s…
-
Base Editing of Human Embryos Avoids Chromosome Loss but Leaves the Mosaicism Problem
NEW YORK, June 9, 2026 — infopulsetoday.com —The embryos were not perfect. Some cells carried the edit. Others did not. That is…
-
Rural cancer death rates fall slower as urban survival improves
For nearly three decades, cancer death rates in the United States have been falling. The turnaround began in 1991. But that good…
-
Ernexa Reports Clean Safety Results for ERNA-101 Ahead of Planned Q4 2026 IND Filing
Cambridge, Mass. — Ernexa Therapeutics is betting on a single cell therapy to crack one of oncology’s hardest nuts: the so-called “cold”…
-
Rural Counties Cut Cancer Deaths Far Less Than Big Cities Since 1991, Studies Show
The gap in cancer survival between urban and rural America is not just a statistic — it carries real, measurable consequences for…
-
Ocular Therapeutix Files Plan Using Single Trial for Wet AMD Drug Approval
A single clinical trial endpoint change, tucked into a regulatory filing plan, could reshape how a common cause of blindness is treated.…
-
Ocular Therapeutix Plans 2026 NDA Filing for Longer-Lasting Wet AMD Drug
Ocular Therapeutix has spent years chasing a wet AMD treatment that could stretch the time between injections from months to something closer…
-
Ocular Therapeutix Plans 2026 NDA Filing for Wet AMD Drug Candidate
Ocular Therapeutix is betting that a partial safety readout, combined with earlier efficacy data, will be enough to get its wet AMD…
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists from one Northern Virginia practice have earned a permanent spot in Washingtonian magazine’s Top Doctors Hall of Fame. The recognition,…
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists at one Virginia practice have now been named to a regional hall of fame for physicians — but the real…
-
Sonire Therapeutics’ Japanese Unit Wins Grant for Ultrasound-Based Cancer Therapy
Pancreatic cancer is one of the most lethal diagnoses a person can receive. Five-year survival rates linger in the single digits. Treatment…
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists at Virginia Cancer Specialists have been inducted into the Washingtonian “Top Doctors” Hall of Fame. The distinction is not given…
-
Sonire Therapeutics Receives $13M Japanese Grant for Non-Invasive Pancreatic Cancer Treatment
Pancreatic cancer is notoriously hard to treat. Tumors hide deep in the abdomen, often diagnosed late. Surgery is brutal. Chemotherapy has limits.…
-
Ernexa Therapeutics Advances ERNA-101 Toward Clinical Trials with IND Filing
Ernexa’s IND Timeline Signals Shift from Lab to Clinic CAMBRIDGE, Mass. — With GMP manufacturing already underway and an IND submission slated…
-
Lymphoma Research Foundation Awards 24 New Research Grants
NEW YORK, June 17 — The Lymphoma Research Foundation, the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
-
Virginia Cancer Specialists: 21 Doctors in Top Docs Hall of Fame
FAIRFAX, June 17 — Virginia Cancer Specialists announced that 21 of its physicians have been named to the Washingtonian “Top Doctors” Hall…
-
Sonire Therapeutics Wins $13M NEDO Grant for Pancreatic Cancer Treatment
PALO ALTO, June 17 — Sonire Therapeutics, a U.S.-based clinical-stage medical device company, has announced a significant development in its pursuit of…
-
Rural areas lag in cancer care as urban survival rates rise
WASHINGTON, June 17 — A dramatic turnaround in cancer treatment and prevention in the United States, which began in 1991, has not…
-
FDA Clears First Human Trial of Partial Epigenetic Reprogramming for Eye Disease
BOSTON, June 11 — Life Biosciences, a Boston-based longevity company, has started the first FDA-approved human clinical trial to turn back time…
-
Google Asks EPA for Permit to Release Up to 32 Million Lab-Bred Mosquitoes
SAN FRANCISCO, June 11 — A subsidiary of Google’s parent company has submitted a request to federal regulators for approval to deploy…
-
Six women in ICU after C-sections at Bikaner hospital; families await answers
The six women who underwent caesarean sections at PBM Hospital in Bikaner are now on dialysis, fighting kidney complications in the intensive…
-
Montreal researchers identify molecular mechanism that sabotages cancer immunotherapy
MONTREAL — For a significant number of cancer patients, the most advanced immunotherapies simply stop working. Tumors that initially shrink eventually grow…
-
Montreal researchers discover SLAMF6 molecule directly shuts down immune cell defenses
MONTREAL — The molecule that shuts down the body’s cancer defenses does not need a middleman. It acts on its own. That…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
























